Skip to Content

Answers (1)

Official Answer Medically reviewed by Drugs.com. Last updated on Mar 12, 2019.
Last Updated: March 11, 2019 J.Stewart BPharm

The number of biosimilars currently approved by the FDA is eighteen.

The most recent approval was Trazimera (trastuzumab-qyyp) on March 11, 2019.

What is a biosimilar?
According the to FDA, a biosimilar is a biological product that is highly similar to and has no clinically meaningful differences from an existing FDA-approved reference product.

Herceptin (trastuzumab) Biosimilars

Rituxan (rituximab) Biosimilars

Neulasta (pegfilgrastim) Biosimilars

Humira (adalimumab) Biosimilars

Neupogen (filgrastim) Biosimilars

Epogen / Procrit (epoetin alfa) Biosimilars

Remicade (infliximab) Biosimilars

Avastin (bevacizumab) Biosimilars

  • Mvasi (bevacizumab-awwb)

Enbrel (etanercept) Biosimilars

More information: What Are Biosimilars? Top Facts You May Not Know

Drugs.com free discount card

Search for questions

Still looking for answers? Try searching for what you seek or ask your own question.

Frequently Asked Questions

What disease is Elzonris (tagraxofusp-erzs) used to treat?

Updated 7 Jan 2019 1 answerFAQ by Drugs.com

How do you use the ProAir Digihaler?

Updated 7 Jan 2019 1 answerFAQ by Drugs.com

What are the brands of sumatriptan?

Updated 5 Feb 2019 1 answerFAQ by Drugs.com

What is botulinum toxin used to treat?

Updated 14 Feb 2019 1 answerFAQ by Drugs.com